article thumbnail

QMS market to value nearly $4b by 2030

European Pharmaceutical Review

billion by 2030. Since most pharmaceutical manufacturers export their products to North America and Europe, the need for documents such as process management, corrective and preventive actions (CAPA), deviations, training, quality management, and product release documents is vital.

article thumbnail

Can AI Help Fix Our Demographic Time Bomb?

MedCity News

By 2030, the U.S. Here’s how to build and train a modern healthcare workforce in the age of AI The post Can AI Help Fix Our Demographic Time Bomb? expects shortages of 200,000 nurses and 124,000 physicians snd similar shortages are already being felt in the U.K. and elsewhere. appeared first on MedCity News.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Medical Video Production: Enhancing Healthcare Communication and Training

Infuse Medical

Whether for marketing, training, or teaching, our carefully created medical videos are meant to captivate, enlighten, and propel outcomes. Whether in a classroom or via web platforms, video materials let healthcare companies offer their employees continuous, high-quality training. billion by 2030, at a CAGR of 33.5%

article thumbnail

U.S. Gastrointestinal Endoscopic Devices Market Growth (2022-2030)

Medico Reach

billion by 2030. Although there has been a decrease in professionals trained in handling endoscopic devices, countries like the US and UK have adapted by training nurse endoscopists. Gastrointestinal Endoscopic Devices Market Growth (2022-2030) appeared first on MedicoReach. billion in 2021. billion by 2027.

article thumbnail

Swedish innovation agency invests in new ATMP QC method

European Pharmaceutical Review

The first data type will be more cost-effective, since sequencing data for training the model, then fine-tuning the model with qPCR data is more accurate. The project, initiated in October 2022, is part of the agency’s plans to make Sweden a key leader in ATMPs by 2030.

article thumbnail

Takeda to invest €300 million in plasma-derived therapy production

European Pharmaceutical Review

We aim to become a net-zero carbon emissions operation by 2030 and have a clear focus on further digitalisation. In addition to the investment in our production capacity, we also invest in the development and training of our employees to keep them abreast of the latest scientific, technical and digital evolutions.

article thumbnail

The Caregiver Vertical: How Pharma Engages

Pharma Marketing Network

By 2030, it is estimated there will be only 4 potential family caregivers per older adult and some are also caring for children of their own. This deserves advance consideration; otherwise, the caregiver may be working without instruction or proper training to deliver essential care.

Pharma 98